NCT04517630View on ClinicalTrials.gov

Renal Biomarkers in AKI and COVID-19

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2021

Conditions
Coronavirus InfectionCovid19SARS (Severe Acute Respiratory Syndrome)AKI
Interventions
DIAGNOSTIC_TEST

urinary NGAL, TIMP-2, IGFBP7, IL-6, viral load and metabolomic

Determine the evolution of NGAL, TIMP-2, IGFBP7, IL-6, viral load and metabolomic at basal, and the 3 , 5 and 7 days after recruitment

Trial Locations (1)

14060

Centro de Investigacion en Enfermedades Infecciosas, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Enfermedades Respiratorias

OTHER_GOV

NCT04517630 - Renal Biomarkers in AKI and COVID-19 | Biotech Hunter | Biotech Hunter